Old Web
English
Sign In
Acemap
>
authorDetail
>
Xue Jun Yang
Xue Jun Yang
Tianjin Medical University
Temozolomide
Dacarbazine
Chemotherapy
Medicine
O-6-methylguanine-DNA methyltransferase
3
Papers
39
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Does Early Postsurgical Temozolomide Plus Concomitant Radiochemotherapy Regimen Have Any Benefit in Newly-diagnosed Glioblastoma Patients? A Multi-center, Randomized, Parallel, Open-label, Phase II Clinical Trial.
2015
Chinese Medical Journal
Ying Mao
Yu Yao
Li Wei Zhang
Yicheng Lu
Zhong-Ping Chen
Jian min Zhang
Song-Tao Qi
Chao You
Ren-zhi Wang
Shuyuan Yang
Xiang Zhang
Ji Sheng Wang
Ju Xiang Chen
Qun Ying Yang
Hong Shen
Zhiyong Li
Xiang Wang
Wen Bin Ma
Xue Jun Yang
Hai Ning Zhen
Liang Fu Zhou
Show All
Source
Cite
Save
Citations (9)
Chemoresistance to temozolomide in human glioma cell line U251 is associated with increased activity of O6-methylguanine-DNA methyltransferase and can be overcome by metronomic temozolomide regimen.
2012
Cell Biochemistry and Biophysics
Qiang Pan
Xue Jun Yang
Hua-min Wang
Xue-tao Dong
Wei Wang
Yu Li
Jing-min Li
Show All
Source
Cite
Save
Citations (30)
Translational medicine about tumor in the central nervous system is not only a concept but also a practice
2011
Chinese Journal of Neuromedicine
Xue Jun Yang
Show All
Source
Cite
Save
Citations (0)
1